This group then followed up reporting significant correlations between expression of Lewis y antigen and CD44 in tissues from ovarian cancer patients, where overexpression of Lewis y and CD44 antigen were strong predictive risk factors for chemotherapeutic drug resistance [57]. The gene discussed is CD44; the disease is ovarian carcinoma.